FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 161 filers reported holding FATE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $374,000 | -29.2% | 9,640 | +6.7% | 0.05% | -38.0% |
| Q4 2021 | $528,000 | -91.1% | 9,038 | -91.0% | 0.08% | -81.1% |
| Q3 2021 | $5,928,000 | -34.1% | 100,000 | -3.5% | 0.42% | -42.6% |
| Q2 2021 | $8,993,000 | -3.0% | 103,600 | -7.9% | 0.73% | +133.0% |
| Q1 2021 | $9,275,000 | +32.0% | 112,500 | +45.5% | 0.31% | +0.6% |
| Q4 2020 | $7,029,000 | +75.5% | 77,300 | -22.9% | 0.31% | +6.9% |
| Q3 2020 | $4,006,000 | +16.5% | 100,200 | 0.0% | 0.29% | +5.8% |
| Q2 2020 | $3,438,000 | +54.4% | 100,200 | 0.0% | 0.27% | +63.1% |
| Q1 2020 | $2,226,000 | – | 100,200 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |